drugset / Trial / NCT01432496

Peritoneal Nebulization of Ropivacaine for Pain Control After Laparoscopic Colectomy

NCT01432496

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess if intraperitoneal nebulization of Ropivacaine 150 mg produces better postoperative pain control than Saline nebulization after laparoscopic colectomy.

Timeline

Start
2011-09
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 150 mg Other

Indications

No indication recorded.